2012-10-01
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome
Publication
Publication
British Journal of Cancer , Volume 107 p. 1409- 1417
Additional Metadata | |
---|---|
Life Sciences (theme 5), Energy (theme 4) | |
Nature Publishing Group | |
British Journal of Cancer | |
Organisation | Life Sciences and Health |
Schramm, A, Schowe, B, Fielitz, K, Heilmann, M, Martin, M, Marschall, T, … Schulte, J.H. (2012). Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome. British Journal of Cancer, 107, 1409–1417.
|